Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chevron Corporation stock logo
CVX
Chevron
$213.30
-0.4%		$195.53
$146.49
▼
$217.65
$421.41B0.510.55 million shs4.36 million shs
CocaCola Company (The) stock logo
KO
CocaCola
$89.04
+0.9%		$86.64
$65.35
▼
$92.49
$383.04B0.3416.93 million shs7.35 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$145.26
+0.9%		$136.51
$77.58
▼
$156.92
$358.47B0.2110.70 million shs3.80 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chevron Corporation stock logo
CVX
Chevron
0.00%+2.74%+7.11%+18.68%+36.23%
CocaCola Company (The) stock logo
KO
CocaCola
0.00%+0.31%+0.76%+9.13%+31.83%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%-4.22%+6.07%+25.21%+73.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chevron Corporation stock logo
CVX
Chevron
$213.30
-0.4%		$195.53
$146.49
▼
$217.65
$421.41B0.510.55 million shs4.36 million shs
CocaCola Company (The) stock logo
KO
CocaCola
$89.04
+0.9%		$86.64
$65.35
▼
$92.49
$383.04B0.3416.93 million shs7.35 million shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$145.26
+0.9%		$136.51
$77.58
▼
$156.92
$358.47B0.2110.70 million shs3.80 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chevron Corporation stock logo
CVX
Chevron
0.00%+2.74%+7.11%+18.68%+36.23%
CocaCola Company (The) stock logo
KO
CocaCola
0.00%+0.31%+0.76%+9.13%+31.83%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%-4.22%+6.07%+25.21%+73.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chevron Corporation stock logo
CVX
Chevron
2.73
Moderate Buy$211.35-1.33% Downside
CocaCola Company (The) stock logo
KO
CocaCola
2.89
Moderate Buy$95.768.42% Upside
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.68
Moderate Buy$151.325.07% Upside

Current Analyst Ratings Breakdown

Latest KO, CVX, and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/10/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
HSBC Holdings plc logo
HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$150.00 ➝ $172.00
9/9/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Leerink Partners logo
Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$127.00 ➝ $161.00
9/8/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$146.00 ➝ $170.00
9/4/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$150.00 ➝ $170.00
9/3/2026
CocaCola Company (The) stock logo
KO
CocaCola
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeBuy (B+) ➝ Buy (A-)
9/3/2026
Chevron Corporation stock logo
CVX
Chevron
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$210.00 ➝ $235.00
9/3/2026
Chevron Corporation stock logo
CVX
Chevron
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$207.00 ➝ $243.00
9/3/2026
Chevron Corporation stock logo
CVX
Chevron
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$226.00 ➝ $230.00
8/25/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/25/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$155.00 ➝ $180.00
8/25/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$145.00 ➝ $170.00
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chevron Corporation stock logo
CVX
Chevron
$189.03B2.24$16.72 per share12.81$95.44 per share2.24
CocaCola Company (The) stock logo
KO
CocaCola
$47.94B7.93$3.26 per share27.09$7.97 per share11.08
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$65.01B5.47$11.43 per share12.60$21.22 per share6.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chevron Corporation stock logo
CVX
Chevron
$12.30B$10.4320.5414.610.639.57%11.09%6.54%10/30/2026 (Estimated)
CocaCola Company (The) stock logo
KO
CocaCola
$13.11B$3.3326.5225.023.4428.56%39.38%13.18%10/20/2026 (Estimated)
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$18.25B$1.25115.2214.916.264.77%16.73%6.13%10/29/2026 (Estimated)

Latest KO, CVX, and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$0.26-$0.13+$0.13-$0.54$16.37 billion$16.61 billion
7/31/2026Q2 2026
Chevron Corporation stock logo
CVX
Chevron
$5.55$6.06+$0.51$6.11$62.72 billion$67.20 billion
7/28/2026Q2 2026
CocaCola Company (The) stock logo
KO
CocaCola
$0.9320$0.97+$0.0380$1.03$13.17 billion$13.37 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Chevron Corporation stock logo
CVX
Chevron
$7.123.32%+5.80%68.26%38 Years
CocaCola Company (The) stock logo
KO
CocaCola
$2.122.40%+4.46%63.66%64 Years
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.402.36%+5.75%272.00%14 Years

Latest KO, CVX, and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.852.61%9/15/20269/15/202610/7/2026
7/15/2026
CocaCola Company (The) stock logo
KO
CocaCola
quarterly$0.532.57%9/15/20269/15/202610/1/2026
7/29/2026
Chevron Corporation stock logo
CVX
Chevron
quarterly$1.783.46%8/19/20268/19/20269/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chevron Corporation stock logo
CVX
Chevron
0.19
1.25
0.98
CocaCola Company (The) stock logo
KO
CocaCola
0.97
1.30
1.12
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1.22
1.32
1.10

Institutional Ownership

CompanyInstitutional Ownership
Chevron Corporation stock logo
CVX
Chevron
72.42%
CocaCola Company (The) stock logo
KO
CocaCola
70.26%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%

Insider Ownership

CompanyInsider Ownership
Chevron Corporation stock logo
CVX
Chevron
0.56%
CocaCola Company (The) stock logo
KO
CocaCola
0.90%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chevron Corporation stock logo
CVX
Chevron
43,0391.98 billion1.96 billionOptionable
CocaCola Company (The) stock logo
KO
CocaCola
65,9004.30 billion4.26 billionOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.47 billion2.46 billionOptionable

Recent News About These Companies

Merck & Co. stock gains as DBS lifts price target and Q2 2026 revenue grows
 |  ad-hoc-news.deA
Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/perspective-therapeutics-announces-clinical-collaboration-101600551.html
Smartphone displaying a rising stock price chart on a desk with glasses, a financial newspaper, and a notebook.
Blue-Chip Stocks Are Looking Anything But Boring With Dividends and Big 2026 Gains (MRK)
...
September 13 at 8:50 AM  |  marketbeat.comhttps://www.marketbeat.com/articles/blue-chip-stocks-are-looking-anything-but-boring-with-dividends-and-big-2026-gains/
DBS Keeps Their Buy Rating on Merck & Company (MRK)
September 12 at 5:45 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MRK/pressreleases/4574497/dbs-keeps-their-buy-rating-on-merck-company-mrk/
Jim Cramer Explains Why Merck (MRK) Is His Fantasy Defense Stock
September 12 at 5:45 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/jim-cramer-explains-why-merck-164911925.html
REVOLUTIONIZING HEALTHCARE: Tempus partners with Merck on AI-driven precision medicine
September 12 at 3:00 PM  |  youtube.comY
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, HSBC Analyst Says
September 12 at 2:50 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31018372
Wall Street Zen Downgrades Merck & Co., Inc. (NYSE:MRK) to Hold
September 12 at 1:56 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31017930
Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen
September 12 at 1:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-merck-co-inc-nyse-mrk-lowered-to-hold-rating-by-wall-street-zen-2026-09-12/
Smith Chas P & Associates PA Cpas Has $46.21 Million Stake in Merck & Co., Inc. $MRK
September 11 at 7:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-smith-chas-p-associates-pa-cpas-has-4621-million-stake-in-merck-co-inc-mrk-2026-09-11/
7,741 Shares in Merck & Co., Inc. $MRK Bought by Talon Private Wealth LLC
September 11 at 7:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-7741-shares-in-merck-co-inc-mrk-bought-by-talon-private-wealth-llc-2026-09-11/
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
September 11 at 3:04 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/mrk-banks-growing-pipeline-drugs-151700275.html
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
September 11 at 3:04 PM  |  247wallst.comhttps://247wallst.com/investing/2026/09/11/moderna-rallies-8-on-2026-melt-up-momentum-even-while-biontech-and-merck-stay-flat/
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
September 11 at 12:20 PM  |  zacks.comhttps://www.zacks.com/stock/news/2988525/mrk-banks-on-growing-pipeline-new-drugs-to-offset-keytruda-loe?cid=cs-stocknewsapi-ft-analyst_blog|quick_take-2988525
Merck builds around Keytruda; prediction markets raise new risks
September 11 at 10:02 AM  |  pharmavoice.comP
Advanced Bioreactor Systems Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)
September 11 at 10:02 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/advanced-bioreactor-systems-market-size-080900177.html
The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK
September 11 at 5:27 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-has-26640-million-position-in-merck-co-inc-mrk-2026-09-11/
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages
September 11 at 4:43 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-merck-co-inc-nyse-mrk-given-consensus-rating-of-moderate-buy-by-brokerages-2026-09-11/
IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK
September 11 at 4:24 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-ipg-investment-advisors-llc-lowers-position-in-merck-co-inc-mrk-2026-09-11/
Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP
September 11 at 3:52 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-merck-co-inc-mrk-shares-sold-by-corient-private-wealth-lp-2026-09-11/
Leerink Partners Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock
September 11 at 3:17 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31016528

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Large oil tanker ship departing a port terminal with storage tanks and cranes visible near the water.
Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
By Jeffrey Neal Johnson | September 2, 2026
Gold-colored concept electric vehicle with a smooth, minimalist body parked outdoors near a building and tree.
Ride-Share Reckoning: Tesla Drives Into Uber's Lane
By Jeffrey Neal Johnson | September 7, 2026
Illustration of a vial with an upward stock price chart and DNA double helix against a city skyline, symbolizing biotech growth.
2 Biotech Stocks Shaping Up for Major Breakouts
By Ryan Hasson | August 22, 2026
Computer monitor displaying the Palantir logo surrounded by data visualization screens showing network maps and charts.
Palantir's Kool-Aid Moment: The Math Behind Karp's Forecast
By Chris Markoch | August 26, 2026
EHang logo overlaid on an autonomous aerial vehicle parked on a rooftop helipad with a city skyline background.
Boarding Call: EHang Secures First-Mover Altitude
By Jeffrey Neal Johnson | September 1, 2026
Chevron stock logo

Chevron NYSE:CVX

$213.30 -0.76 (-0.35%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

CocaCola stock logo

CocaCola NYSE:KO

$89.04 +0.75 (+0.85%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$145.26 +1.33 (+0.92%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas